echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Interview with Zhang Chuan of Shanghai Jiaotong University: Nucleic acid nanogels realize synergistic cancer photoimmunotherapy

    Interview with Zhang Chuan of Shanghai Jiaotong University: Nucleic acid nanogels realize synergistic cancer photoimmunotherapy

    • Last Update: 2022-05-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Immune escape is one of the key causes of tumorigenesis and progression, helping tumor cells evade lethal attack from immune cells


    Immune escape is one of the key causes of tumorigenesis and progression, it helps tumor cells evade lethal attack from immune cells fatal attack

    Immune checkpoint blockade (ICB) targeting the PD-1/PD-L1 pathway can modulate the tumor microenvironment and restore cytotoxic T lymphocyte (CTL) function, a discovery that has changed the cancer treatment landscape and has implications for a variety of cancers.


    However, due to insufficient T cell infiltration in solid tumor tissues, PD-1/PD-L1 immune checkpoint blockade therapy has an insufficient response rate and is only effective in approximately 20% of cancer patients


    On April 20, 2022, Zhang Chuan's research team from the School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, together with Li Yuehua from the Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, and the Yu Naval Research Team from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, published a paper entitled: Copackaging photosensitizer and PD-Research paper on L1 siRNA in a nucleicacid nanogel for synergistic cancer photoimmunotherapy


    Science Advances Science Advances Copackaging photosensitizer and PD-L1 siRNA in a nucleicacid nanogel for synergistic cancer photoimmunotherapyCopackaging photosensitizer and PD-L1 siRNA in a nucleicacid nanogel for synergistic cancer photoimmunotherapy

    The research developed a nanogel that can simultaneously load PD-L1 siRNA and photosensitizer PPA, which can play a two-pronged approach to produce stronger photodynamic therapy effect, kill tumor cells, and at the same time significantly induce tumor cell immunity Primary death, inhibition of tumor metastasis


    Zhang Chuan of Shanghai Jiaotong University, Li Yuehua of the Sixth People's Hospital Affiliated to Shanghai Jiaotong University, and researcher Yu Haijun of Shanghai Institute of Materia Medica, Chinese Academy of Sciences are the co-corresponding authors of the paper

    Dr.


    Zhang Chuan graduated from Tsinghua University with a bachelor's degree and a master's degree.


    In 2014, Zhang Chuan returned to China to join the School of Chemistry and Chemical Engineering of Shanghai Jiao Tong University and established his own laboratory


    Dr.


    Dr.


    Immune Checkpoint Blockade Therapy (ICB) is an Effective Approach to Current Cancer Treatment Immune Checkpoint Blockade Therapy (ICB) is an Effective Approach to Current Cancer Treatment

    Theoretically, photodynamic therapy (PDT) can be well combined with immune checkpoint blockade therapy (ICB) to synergistically exert anti-tumor effects


    Photodynamic therapy (PDT) can be well combined with immune checkpoint blockade therapy (ICB) to synergistically exert anti-tumor effects

    Dr.


    The hydrophobic nature of photosensitizers, limited laser penetration, and hypoxia and immunosuppressive tumor microenvironment often hinder the therapeutic efficacy of photodynamic therapy (PDT)


    To overcome these problems, direct knockdown of PD-1/PD-L1 expression using small interfering RNA (siRNA) is an effective alternative to enhance T cell-mediated tumor killing


    Direct knockdown of PD-1/PD-L1 expression using small interfering RNA (siRNA) is an effective alternative to enhance T cell-mediated tumor killing .


    In recent years, DNA has received increasing attention as a novel non-cationic carrier, and DNA nanostructures can be used for drug delivery due to its good biocompatibility


    In order to solve this problem, Zhang Chuan's team proposed a self-assembled nucleic acid nanogel platform for efficient delivery of functional nucleic acids (such as siRNA, miRNA, Cas9/sgRNA complexes, etc.
    ) Gel-assembled crosslinkers and embedded in three-dimensional structures
    .

    In this latest study, Zhang Chuan's team designed a PD-L1 siRNA cross-linker on the basis of the previous study, and the pheophytin A (PPA) photosensitizer was grafted to the DNA of the pre-designed phosphorothioate modification site.
    On the backbone, the four PPA-grafted DNA thus synthesized can be assembled into a tetrahedral framework
    .
    Further binding to PD-L1 siRNA linker through supramolecular self-assembly forms a nanogel co-loaded with siRNA and PPA
    .

    In this nanogel system, hydrophilic DNA facilitates the uniform solubilization of PPA
    .
    Therefore, the nanogels containing photosensitizers exhibited excellent water solubility, which promoted the generation of reactive oxygen species and caused significant tumor cell immunogenic cell death
    .
    Meanwhile, the siRNA released from the nanogels also down-regulated the expression of PD-L1 in tumor cells, thereby synergistically promoting cytotoxic T lymphocyte (CTL)-mediated tumor killing
    .
    This results in strong inhibition of primary and distant tumors
    .

    Overall, this study developed a non-cationic nanocarrier platform for simultaneous delivery of immune checkpoint blockade therapy and photodynamic therapy with favorable biosafety, excellent photodynamic efficiency, promotion of immune responses, and effective tumor Inhibition and anti-metastatic efficiency, paving the way for the development of novel combination anti-tumor therapies
    .

    Dr.
    Zhang Chuan said that in addition to the use of this nucleic acid nanogel for cancer treatment, the team mainly considers some indications that can be locally administered, and it can be made into a macro-gel injectable form, and relevant research and exploration are currently underway.
    work
    .

    Dr.
    Zhang Chuan also said that from the current experimental results, the in vivo pharmacokinetic properties of the nanogels are not ideal, and the circulation time is short
    .
    In addition, the endosome escape ability of spherical nucleic acid (SNA) itself is usually not very good, which affects the therapeutic effect of the loaded functional nucleic acid
    .
    In this study, light is used to promote nanogels to achieve endosomal escape.
    In the future, further exploration and improvement are needed in the above two aspects to further enhance the therapeutic effect
    .



    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.